Cinacalcet and concurrent intravenous calcitriol for treatment of secondary hyperparathyroidism in dialysis patients compared with intravenous calcitriol alone
Not Applicable
- Conditions
- secondary hyperparathyroidism
- Registration Number
- JPRN-UMIN000003438
- Lead Sponsor
- 1.Division of Internal medicine, Seseragi hospital 2.Department of Medicine & Biological Science Gunma University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.severe liver dysfunction or cirrhosis 2.parathyroidectomy within the previous 24 weeks 3.patients receiving or likely to use within 52 weeks of corticosteroid except for external use 4.use of bisphosphonate 5.pregnant or nursing 6.unsuitable patients
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.serum fibroblast growth factor 23 (FGF23)levels 2.bone metabolism markers.
- Secondary Outcome Measures
Name Time Method 1.bone mineral density. 2.serum biochemistry findings 3.the number and findings of enlarged parathyroid gland.